Skip to content

Construction of artificial intelligence-assisted prostate tumor early diagnosis system based on surface enhanced Raman spectroscopy

Construction of artificial intelligence-assisted prostate tumor early diagnosis system based on surface enhanced Raman spectroscopy

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037082
Enrollment
Unknown
Registered
2020-08-26
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Index test:Artificial&#32
tumor&#32
early&#32
diagnosis&#32
system&#32
based&#32
on&#32

Sponsors

Renji Hospital Affiliated to Medical School of Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Patients who have undergone prostate puncture or prostate surgery in our hospital; 2. To evaluate the patient's physical strength (ECoG 0-2), blood routine, liver and kidney function, cardiac function and tumor load; 3. After being fully informed of the purpose and possible risks of the study, the patient agreed to participate in the trial and signed the "informed consent form for clinical sample use".

Exclusion criteria

Exclusion criteria: 1. Patients with previous history of other tumors; 2. Patients who have previously received allogeneic hematopoietic stem cell transplantation or solid organ transplantation; 3. Patients with a history of psychotropic substance abuse and unable to quit or with a history of mental disorders; 4. Patients who are unable to cooperate or refuse to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
surface enhanced Raman spectroscopy;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactPan Jiahua

Renji Hospital Affiliated to Medical College of Shanghai Jiaotong University

jiahua.pan@outlook.com+86 13916989510

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026